Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about INCY

Recent news which mentions INCY

< Previous 1 2 3 4 5 6 7 8 9 Next >
Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B
Tickers INCY MOR NEWS NVS
Tags Benzinga Market News Large Cap
From Benzinga
Why Is MorphoSys (MOR) Stock Up 50% Today?
Tickers INCY MOR NVS
Tags MOR Market News NVS
From InvestorPlace
MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer
Tickers INCY MOR NEWS NVS
Tags Movers & Shakers INCY why it's moving
From Benzinga
3 Pharma Stocks Could Be the Pills Your Portfolio Needs
Tickers EXEL INCY PFE SGEN
Tags EXEL Stocks to Buy INCY
From InvestorPlace
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
Tickers ACRS INCY NEWS ROIV
Tags Penny Stocks Briefs ACRS
From Benzinga
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
Tickers ABCL BAYRY DNA GOOG
Tags REGN INCY RXRX
From InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in December
Tickers INCY KNSA NBIX RHHBY
Tags NBIX NASDAQ:KNSA,OTCMKTS:RHHBY,NASDAQ:NBIX,NASDAQ:INCY Market News
From InvestorPlace
Expert Ratings for Incyte
Tickers INCY
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
What's Up With Incyte Stock Lately?
Tickers INCY
Tags Market News Benzinga INCY
From Benzinga
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
Tickers ALB ALGN ALK APA
Tags LKQ SPY META
From Benzinga
Goldman Sachs Downgrades Incyte Amid Concerns Over Jakafi Studies, Competitiveness
Tickers INCY
Tags Briefs Price Target Equities
From Benzinga
The Latest Analyst Ratings for Incyte
Tickers INCY
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024
Tickers CRSP INCY SWAV
Tags SWAV NASDAQ:SWAV,NASDAQ:CRSP,NASDAQ:INCY INCY
From InvestorPlace
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
Tickers BNTX CORT GMAB HALO
Tags Stocks to Buy CORT KNSA
From InvestorPlace
Goldman Sachs Maintains Buy Rating for Incyte: Here's What You Need To Know
Tickers INCY
Tags INCY Benzinga Analyst Ratings
From Benzinga
Earnings Outlook For Incyte
Tickers INCY
Tags BZI/EP Market News Earnings
From Benzinga
Quant Ratings Updated on 73 Stocks
Tickers ABT AWK CL CNI
Tags GIS Market Analysis F, GM, STLA, ABT, AWK, CL, CNI, CSL, EXC, GD, GIS, INCY, INVH
From InvestorPlace
Expert Ratings for Incyte
Tickers INCY
Tags INCY BZI/AAR Benzinga
From Benzinga
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
Tickers EXEL INCY JAZZ
Tags Market News INCY Stocks to Buy
From InvestorPlace
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
Tickers BMY GSK INCY
Tags Trading Ideas Biotech BMY
From Benzinga
Analyst Ratings for Incyte
Tickers INCY
Tags BZI/AAR INCY Benzinga
From Benzinga
Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share
Tickers INCY
Tags Earnings Briefs Health Care
From Benzinga
Incyte's Earnings Outlook
Tickers INCY
Tags BZI/EP Benzinga INCY
From Benzinga
Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings
Tickers ACCD AIR ARKQ ARKW
Tags Iridium Communications IRDM SPOT
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
Tickers ABBV AGLE AI AVNS
Tags VRCA ZS X
From Benzinga
Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End
Tickers INCY SNDX
Tags Small Cap INCY Briefs
From Benzinga
'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla
Tickers ARE ASTS CNC FRT
Tags ASTS FRT Penny Stocks
From Benzinga
Incyte Skin Disease Drug Meets Primary Goal In Late-Stage Study In Children
Tickers INCY
Tags Briefs INCY General
From Benzinga
Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape
Tickers INCY SNDX
Tags Briefs SNDX Health Care
From Benzinga
2 Low-Priced Stocks That Could Make You Richer
Tickers ACRS AGEN AXSM BMY
Tags VKTX BMY MRK
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.